SG Tells Justices To Reject Amgen Patent Enablement Case
The U.S. solicitor general says that the U.S. Supreme Court should not consider Amgen's appeal of a Federal Circuit decision tossing its jury win against Sanofi and Regeneron Pharmaceuticals Inc. over...To view the full article, register now.
Already a subscriber? Click here to view full article